My Northwestern Medicine January 31, 2024

Experimental Drug May Slow Childhood Brain Tumors

Experimental Drug May Slow Childhood Brain Tumors

The drug tovorafenib may halt the growth of or shrink some childhood brain tumors, according to a clinical trial published in Nature Medicine.

Read more »

Decorated Nanoparticles Prevent Allergic Reactions

Northwestern University scientists have developed the first selective nanoparticle therapy to prevent allergic reactions, which can range in severity from itchy hives and watery eyes to trouble breathing and even death.

Read more »

As Patients Live Longer, New Criteria Needed for Prostate Cancer Trials

A lack of cancer progression could be used as a surrogate for overall survival in newly metastatic prostate cancer clinical trials, according to a new analysis.

Read more »

COVID-19 Vaccines Highly Effective for Children During Delta and Omicron Waves, Study Finds

The Pfizer BioNTech BNT162b2 vaccine was highly effective in preventing severe COVID-19 infections in children and adolescents during the Delta and Omicron variants, according to a recent nationwide study.

Read more »

Northwestern Medicine Expands Mobile Stroke Unit Coverage

With coverage now including south Elgin, the unit provides, on average, life-saving treatment 30 minutes faster than with traditional transport.

Read more »

What It’s Like to Live With Aphasia

The language disorder hinders a person’s ability to communicate. Two people share their journeys and how they’ve found community.

Read more »

Have an idea for the newsletter or a comment on this issue?

Contact Us »